Aldeyra Therapeutics (ALDX) News Today $5.01 -0.15 (-2.81%) As of 01:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALDX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Aldeyra says FDA accepted resubmitted marketing application for lead drug3 hours ago | msn.comAldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye DiseaseJuly 17 at 7:00 AM | businesswire.comAldeyra Therapeutics (ALDX) Upgraded to Strong Buy: What Does It Mean for the Stock?July 15 at 2:05 PM | msn.comAldeyra Therapeutics (NASDAQ:ALDX) Stock Passes Above 50-Day Moving Average - Should You Sell?July 8, 2025 | marketbeat.comAldeyra Therapeutics: Pivotal FDA Decision After Reproxalap's Chamber DataJuly 2, 2025 | seekingalpha.comAldeyra stock jumps after FDA agreement on cancer drug trial designJune 26, 2025 | au.investing.comAldeyra Shares Climb on FDA Backing for PVRL Drug Trial DesignJune 26, 2025 | msn.comPFG Investments LLC Sells 295,997 Shares of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX)June 26, 2025 | marketbeat.comAldeyra Therapeutics (NASDAQ:ALDX) Upgraded to Hold at Wall Street ZenJune 21, 2025 | marketbeat.comAldeyra resubmits Reproxalap's marketing application to FDAJune 18, 2025 | msn.comAldeyra Therapeutics (NASDAQ:ALDX) Shares Pass Above Fifty Day Moving Average - What's Next?June 17, 2025 | marketbeat.com161,926 Shares in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Purchased by Millennium Management LLCJune 7, 2025 | marketbeat.comAldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare ConferenceMay 29, 2025 | businesswire.comD. E. Shaw & Co. Inc. Sells 146,198 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX)May 26, 2025 | marketbeat.comQ3 Earnings Forecast for ALDX Issued By Leerink PartnrsMay 24, 2025 | marketbeat.comHC Wainwright Issues Positive Estimate for ALDX EarningsMay 23, 2025 | marketbeat.comAldeyra Therapeutics (NASDAQ:ALDX) Raised to "Sell" at StockNews.comMay 23, 2025 | marketbeat.comHC Wainwright Has Strong Estimate for ALDX FY2029 EarningsMay 22, 2025 | marketbeat.comAldeyra Therapeutics' (ALDX) "Buy" Rating Reiterated at HC WainwrightMay 21, 2025 | marketbeat.comAldeyra Therapeutics Inc.May 17, 2025 | barrons.comAldeyra Therapeutics, Inc (NASDAQ:ALDX) Shares Purchased by Dimensional Fund Advisors LPMay 16, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra Therapeutics, Inc. – ALDXMay 13, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDXMay 12, 2025 | prnewswire.comALDX SECURITIES UPDATE: Aldeyra Therapeutics Investors with Losses may have been affected by Securities Violations – Contact BFA Law (NASDAQ:ALDX)May 7, 2025 | globenewswire.comAldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter – Hagens BermanMay 6, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDXMay 6, 2025 | prnewswire.comInvesco Ltd. Cuts Holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX)May 6, 2025 | marketbeat.comAldeyra Therapeutics Schedules Conference Call and Webcast to Announce Topline Results from Phase 3 Dry Eye Disease Clinical Trials of ReproxalapMay 5, 2025 | finance.yahoo.comAldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA ResubmissionMay 5, 2025 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDXMay 5, 2025 | globenewswire.comShort Interest in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Grows By 21.4%May 5, 2025 | marketbeat.comALDX SECURITIES ALERT: Lose Money on Aldeyra Therapeutics, Inc.? Contact BFA Law about Securities Investigation (NASDAQ:ALDX)May 5, 2025 | globenewswire.comALDX INQUIRY NOTICE: Aldeyra Therapeutics (NASDAQ:ALDX) Investors may have been affected by Securities Violations — Contact BFA LawMay 4, 2025 | morningstar.comM683 Capital Management LLC Purchases Shares of 290,000 Aldeyra Therapeutics, Inc (NASDAQ:ALDX)May 4, 2025 | marketbeat.comALDX INQUIRY NOTICE: Aldeyra Therapeutics (NASDAQ:ALDX) Investors may have been affected by Securities Violations -- Contact BFA LawMay 3, 2025 | globenewswire.comAldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter – Hagens BermanMay 1, 2025 | globenewswire.comALDX INVESTIGATION: Aldeyra Therapeutics (NASDAQ:ALDX) Investors with Losses are Urged to Contact BFA Law about its Investigation into the CompanyMay 1, 2025 | globenewswire.comAldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter – Hagens BermanApril 29, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDXApril 29, 2025 | globenewswire.comALDX Investors Have Opportunity to Join Aldeyra Therapeutics, Inc. Fraud Investigation with the Schall Law FirmApril 29, 2025 | prnewswire.comALDX ALERT: Aldeyra Therapeutics (NASDAQ:ALDX) Investors are Reminded of Pending Securities Investigation – Contact BFA LawApril 29, 2025 | globenewswire.comRaymond James Financial Inc. Makes New $3.63 Million Investment in Aldeyra Therapeutics, Inc (NASDAQ:ALDX)April 29, 2025 | marketbeat.comBragar Eagel & Squire, P.C. Is Investigating TechTarget and Aldeyra and Encourages Investors to Contact the FirmApril 28, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDXApril 28, 2025 | prnewswire.comALDX SHAREHOLDER REMINDER: Aldeyra Therapeutics, Inc. Investors are Reminded to Contact BFA Law about Securities InvestigationApril 28, 2025 | markets.businessinsider.comALDX SHAREHOLDER REVIEW: Aldeyra Therapeutics (NASDAQ:ALDX) is being Investigated after 75% Stock Drop – Investors are Urged to Contact BFA LawApril 27, 2025 | globenewswire.comALDX SHAREHOLDER ALERT: BFA Law Reminds Aldeyra Therapeutics, Inc. Investors of the Continuing Securities InvestigationApril 26, 2025 | markets.businessinsider.comAldeyra Therapeutics (ALDX) to Release Quarterly Earnings on ThursdayApril 26, 2025 | marketbeat.comRosen Law Firm Encourages Aldeyra Therapeutics, Inc. ...April 25, 2025 | gurufocus.comRosen Law Firm Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – ALDXApril 25, 2025 | businesswire.com Get Aldeyra Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALDX and its competitors with MarketBeat's FREE daily newsletter. Email Address ALDX Media Mentions By Week ALDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALDX News Sentiment▼1.240.96▲Average Medical News Sentiment ALDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALDX Articles This Week▼43▲ALDX Articles Average Week Get Aldeyra Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CALT News Today ELVN News Today GPCR News Today CDTX News Today ARDX News Today PRAX News Today PROK News Today COLL News Today AKBA News Today AMPH News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALDX) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aldeyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aldeyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALDX Stock Alerts